ALPRE — Predilife SA Share Price
0.000.00%
Last trade - 00:00- €16.13m
- €19.20m
- €0.32m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 51.89 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -357.67% | ||
| Return on Equity | n/a | ||
| Operating Margin | -1339.24% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.02 | 0.05 | 0.14 | 0.29 | 0.32 | 0.69 | 1.04 | 79.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Predilife SA is a France-based company specialized in the development of predictive tests in the medical industry. The Company operates mainly in the field of oncology. Predilife offers MammoRisk, which is a predictive breast cancer test that combines medical imaging thanks to a proprietary software, DenSeeMammo, Big Data and statistics through a scoring tool and genetic profiles via a polygenic risk score (PRS). The image is analysed in order to extract the breast density and the first breast cancer risk factor. In addition, The technology used by MammoRisk makes it possible to evaluate from a database of individuals tracked over time, the risks of an individual to develop cancer compared to the fate of his/her closest neighbors through a database of a number of American and French women.
Directors
- Stephane Ragusa CHM (51)
- Pierre Verdet DCE
- Emilien Gauthier CTO
- Valerie Helin OTH
- Antoine Bricard DRC (47)
- Charles Vilgrain DRC (42)
- Ombline De Villele IND (47)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- April 5th, 2004
- Public Since
- December 21st, 2018
- No. of Employees
- 19
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 3,699,749
- Address
- Igr Campus Cancer 1 Batiment Maurice, VILLEJUIF, 94805
- Web
- https://www.predilife.com
- Phone
- +33 142114211
- Auditors
- MAZARS
Upcoming Events for ALPRE
Similar to ALPRE
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Acticor Biotech SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
FAQ
What is the Predilife SA share price?
As of Today at 21:42 UTC, shares in Predilife SA are trading at €4.36. This share price information is delayed by 15 minutes.
How has the Predilife SA share price performed this year?
Shares in Predilife SA last closed at €4.36 and the price had moved by -22.14% over the past 365 days. In terms of relative price strength the Predilife SA share price has underperformed the FTSE Global All Cap Index by -28.07% over the past year.
What are the analyst and broker recommendations for Predilife SA?
The overall consensus recommendation for Predilife SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Predilife SA dividend yield?
Predilife SA does not currently pay a dividend.
Does Predilife SA pay a dividend?
Predilife SA does not currently pay a dividend.
When does Predilife SA next pay dividends?
Predilife SA does not currently pay a dividend.
How do I buy Predilife SA shares?
To buy shares in Predilife SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Predilife SA?
As of the previous close price of €4.36, shares in Predilife SA had a market capitalisation of €16.13m.
Where are Predilife SA shares listed?
Here are the trading details for Predilife SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALPRE
What kind of share is Predilife SA?
Based on an overall assessment of its quality, value and momentum Predilife SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Predilife SA share price forecast for 2025?
The analyst consensus target price for shares in Predilife SA is €20.90. That is 379.36% above the last closing price of €4.36.
Analysts covering Predilife SA currently have a consensus Earnings Per Share (EPS) forecast of -€1.20 for the next financial year.
Find out moreWhat is the trend in the Predilife SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Predilife SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -33.28%.
As of the last closing price of €4.36, shares in Predilife SA were trading -13.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Predilife SA PE Ratio?
The Predilife SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €4.36.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Predilife SA?
Predilife SA's management team is headed by:
- Stephane Ragusa - CHM
- Pierre Verdet - DCE
- Emilien Gauthier - CTO
- Valerie Helin - OTH
- Antoine Bricard - DRC
- Charles Vilgrain - DRC
- Ombline De Villele - IND